Endeavor BioMedicines

Drug Discovery

Endeavor BioMedicines is a private drug discovery company. It has raised $133 million across 2 recorded rounds; the latest was a $133 million Series C in Apr 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$132.5M
Last round
Later Stage VC (Series C)
Apr 2024
Valuation — not yet established

No valuation for Endeavor BioMedicines is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($132.5M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Endeavor BioMedicines
  • ·34 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Endeavor BioMedicines funding history

2 rounds
DateRoundRaisedPost-money
Apr 2024Later Stage VC (Series C)$132.5M▮
Jan 2022Later Stage VC$89.1M▮
Unlock post-money valuations

Membership and data by Private Market View

Recent activity

In the last 90 days, Endeavor BioMedicines's record added 4 institutional fund marks (latest period Jul 2026).

How much has Endeavor BioMedicines raised?

Endeavor BioMedicines has raised $133 million across 2 recorded rounds since 2022. The largest was an $89.1 million later-stage round in Jan 2022; the most recent was a $133 million Series C in Apr 2024.

Endeavor BioMedicines has filed 2 Form Ds with the SEC since 2022, most recently in May 2024 ($133 million sold to 32 investors).

Institutional holders and vehicles

4 SEC-registered funds reported 34 fair-value marks on Endeavor BioMedicines between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

How Endeavor BioMedicines's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Endeavor BioMedicines, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →

Frequently asked about Endeavor BioMedicines

How much has Endeavor BioMedicines raised?
Endeavor BioMedicines has raised $132.5M in total funding across 2 recorded rounds.
When did Endeavor BioMedicines last raise?
Endeavor BioMedicines last raised in Apr 2024 (Later Stage VC (Series C)), raising $132.5M.